Cancer BiologybioRxivPreprint
Design of a systemic small molecule clinical STING agonist using physics-based simulations and artificial intelligence
B. K. Allen, M. M. Kulkarni, B. Chamberlain…·W. Sherman
This paper designs a small molecule STING agonist, SNX281, using computational methods and AI, showing systemic activity and antitumor effects in mice.
DOI 10.1101/2022.05.23.493001